Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patients.
第一作者:
C,Seidel
第一单位:
Department of Hematology, Hannover Medical School, Carl-Neuberg Str. 1, 30625 Hannover, Germany.
作者:
医学主题词
成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);癌, 肾细胞(Carcinoma, Renal Cell);疾病恶化(Disease Progression);剂量效应关系, 药物(Dose-Response Relationship, Drug);女(雌)性(Female);人类(Humans);吲哚类(Indoles);肾(Kidney);肾肿瘤(Kidney Neoplasms);男(雄)性(Male);中年人(Middle Aged);肾切除术(Nephrectomy);姑息疗法(Palliative Care);蛋白酪氨酸激酶类(Protein-Tyrosine Kinases);吡咯类(Pyrroles);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome)
DOI
10.1007/s00345-010-0642-3
PMID
21258806
发布时间
2021-10-20
- 浏览21
World journal of urology
355-60页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



